Settlement agreement addes major boost to diabetes research
Eight-year-old class action lawsuit over the diabetes drug Rezulin ended in a settlement that can be called a major boost for the diabetes research in the state. The sum is a part of the $17.1 million settlement agreement in a lawsuit filed against the owner of the drug, Warner-Lambert Co. and Parke-Davis.
Because a number of individuals who were eligible to receive damages did not step forward to claim their money, nearly $8 million of the settlement remained, leaving defense counsel Michael Farrell and plaintiff counsel Scott Segal with an opportunity to help the state’s two major universities in their efforts to fight against and better understand diabetes.
Marshall’s funds will be used to help its diabetes center promote better treatment of diabetes issues and add a new focus on diabetes and related disorders to its mobile medical center, which travels around the state performing cancer screenings in rural areas.
Additional funds will go into Marshall’s endocrinology fellowship.
Segal said,
“Dr. Piedimonte is a world-renowned researcher and West Virginia has one of the worst childhood diabetes problems in our country. Dr. Piedimonte is interested in studying, on a wide population basis, the interaction of diabetes, obesity and asthma in children to better help the medical community to understand the problem and how to start tackling the problem. “
Source: The Register Herald
Filed under Class Action, Medical Malpractice, Settlements
You may also like to read
- Novo Nordisk Sues Pfizer For Infringement of Patent of Inhaled Insulin Treatment for Diabetes
- Westchester restaurants to post calories on their menus
- Future of Life Sciences Research Board To Be Decided Soon
- WSB Financial Group goes for settlement agreement
- Philadelphia based drug maker faces lawsuits
- Aerosonic Corp. Settles A Class Action Lawsuit for $5.4-Million
- Class Action Lawsuit Settlement by FMF Capital Group Ltd.
- Unlawful Distribution of “PC-Spes” Class Action Lawsuit Settlement by International Medical Research, Inc.
- Virginia resident files lawsuit against San Diego-based diabetes drug maker
- Ryan's Restaurant Group, Inc. Announces Settlement of Shareholder Class Action Lawsuit
